Skip to main content
Log in

Role of natural killer cells in experimental murine myocarditis

  • Experimental Studies In Myocarditis And Cardiomyopathy
  • Published:
Springer Seminars in Immunopathology Aims and scope Submit manuscript

Conclusions

Infection of adolescent CD-1 mice with CVB3 activates NK cells. These activated NK cells can lyse infected fibroblasts in vitro and their transfer into mice prior to inoculation with CVB3 can reduce virus titers in heart tissues. If mice are depleted of NK cells prior to and throughout a CVB3 infection, myocarditic lesions show a comparatively greater pathology in the form of severe dystrophic calcification than in infected mice with an intact NK cell system. Also NK cell-depleted mice have significantly higher virus titers in heart tissues. These data suggest a role for NK cells in the infected mouse, i. e., that they reduce virus titers through lysis of infected cells and thereby reduce the severity of myocarditis. In keeping with such a defensive role is the finding of NK cells among the first inflammatory cells forming the nascent CVB3-induced focal myocarditic lesion. Paradoxically, NK cells remain in the mature lesion up to 10 days p.i. and may thus contribute to pathology. Further studies on whether these long-term residents release cytotoxic factors which continue to damage myocytes in absence of significant virus titers in heart tissues must be performed. These studies are now feasible because of the recent development of monoclonal antibodies against NK cytotoxic factor [30]. Finally, diet can adversely effect generation of activated NK cells in CVB3-inoculated mice and this finding may have significance for health-conscious human beings.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Baron S, Dianzani F, Stanton J (1982) The interferon system: a review to 1982. Tex Rep Biol Med 41: 1

    Google Scholar 

  2. Bonavida B, Wright SC (1986) Role of natural killer cytotoxic factors in the mechanism of target-cell killing by natural killer cells. J Clin Immunol 6: 1

    Google Scholar 

  3. Biron CA, Welsh RM (1982) Activation and role of natural killer cells in virus infections. Med Microbiol 170: 155

    Google Scholar 

  4. Biron CA, Welsh RM (1982) Blastogenesis of natural killer cells during viral infection in vivo. J Immunol 129: 2788

    Google Scholar 

  5. Casali, P, Trinchieri G (1984) Natural killer cells in viral infections. In: Notkins AL, Oldstone MAB (eds) Concepts in viral pathogenesis. Springer, New York Berlin Heidelberg, pp 11–19

    Google Scholar 

  6. Dianzani F, Capbianchi MR, Matteucci D, Bendinelli M (1988) The role of interferon in picornavirus infections. In: Bendinelli M, Friedman H (eds) Coxsackieviruses A general update. Plenum Press, New York, p 65–80

    Google Scholar 

  7. Dyerberg J (1986) Linolenate-derivated polyunsaturated fatty acids and prevention of athrosclerosis. Nutr Rev 44: 125

    Google Scholar 

  8. Fernandes G, Gauntt CJ, Sandburg L, Freidrich W, Meydani SN (1987) Effect of high fish intake on vitamin E levels, NK activity and susceptibility to viral-induced myocarditis in lupus-prone mice. Arthritis Rheum 30: S 123

    Google Scholar 

  9. Gauntt CJ (1987) Cellular and humoral immune responses in coxsackieviruses myocarditis. In: Kawai C, Abelmann WH, Matsumori A (eds) Cardiomyopathy update 1. Pathogenesis of myocarditis and cardiomyopathy. Recent experimental and clinical studies. University of Tokyo Press, Tokyo, p 49–61

    Google Scholar 

  10. Gauntt CJ, Paque RE, Trousdale MD, Gudvangen RJ, Barr DT, Lipotich GJ, Nealon TJ, Duffey PS (1983) Temperature-sensitive mutant of coxsackievirus B3 (CVB3) establishes resistance in neonatal mice which protects them during adolescence against CVB3-induced myocarditis. Infect Immun 39: 851

    Google Scholar 

  11. Gauntt CJ, Arizpe HM, Kung JT, Ogilvie KK, Cheriyan UO (1985) Antimyocarditic activity of the guanine derivative BIOLF-70 in a coxsackievirus B3 murine model. Antimicrob Agents Chemother 27: 184

    Google Scholar 

  12. Gauntt CJ, Godeny EK, Lutton CW (1988) Host factors regulating viral clearance. Pathol Immunopathol Res 7: 251

    Google Scholar 

  13. Godeny EK, Gauntt CJ (1986) Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J Immunol 137: 1695

    Google Scholar 

  14. Godeny EK, Gauntt CJ (1987) Murine natural killer cells limit coxsackievirus B3 replication. J Immunol 139: 913

    Google Scholar 

  15. Godeny EK, Gauntt CJ (1987) In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol 129: 267

    Google Scholar 

  16. Godeny EK, Gauntt CJ (1987) Interferon and natural killer cell activity in coxsackie virus B3-induced murine myocarditis. Eur Heart J [Suppl J] 8: 433

    Google Scholar 

  17. Godeny EK, Cassling RS, Gauntt CJ (1987) Studies on the mechanism(s) of resistance to coxsackie virus B3 (CVB3)-induced myocarditis at adolescence in mice vaccinated at birth with a temperature-sensitive mutant of CVB3. Eur Heart J [Suppl J] 8: 403

    Google Scholar 

  18. Godeny EK, Arizpe HM, Gauntt CJ (1988) Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol 1: 305

    Google Scholar 

  19. Goodnight SH, Harris WS, Connor WE, Illingworth JR (1982) Polyunsaturated fatty acids hyperlipidemia and thrombosis. Arteriosclerosis 2: 87

    Google Scholar 

  20. Huber SA, Job LP (1981) Cellular immune mechanisms in coxsackievirus group B, type 3 induced myocarditis in BALB/c mice. In: Spitzer JJ (ed) Myocardial injury. Plenum Press, New York, pp 491–508

    Google Scholar 

  21. Huber SA, Job LP, Woodruff JF (1981) Sex-related differences in the pattern of coxsackievirus B3-induced immune spleen cell cytotoxicity against virus-infected myofibers. Infect Immun 32: 68

    Google Scholar 

  22. Kurane I, Binn LN, Bancroft WH, Ennis FA (1985) Human lymphocyte responses to hepatitis A virus-infected cells: interferon production and lysis of infected cells. J Immunol 135: 2140

    Google Scholar 

  23. Levy RC, Rifkind B, Dennis B, Ernest N (1979) Nutrition, lipids and coronary heart disease. Raven Press, New York, pp 247–364

    Google Scholar 

  24. Lutton CW, Gauntt CJ (1985) Ameliorating effect of IFN-β and anti-IFN-β on coxsackievirus B3-induced myocarditis in mice. J Interferon Res 5: 137

    Google Scholar 

  25. Lutton CW, Gauntt CJ (1986) Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts. J Virol 60: 294

    Google Scholar 

  26. Lutton CW, Gudvangen RJ, Nealon TJ, Paque RE, Gauntt CJ (1985) Cellular immune responses in mice challenged with an amyocarditic variant of coxsackievirus B3. J Med Virol 17: 345

    Google Scholar 

  27. McManus BM, Cassling RS, Gauntt CJ (1987) Immunologic basis of myocardial injury. Cardiovasc Clin 18: 163

    Google Scholar 

  28. Meydani SN, Yogeeswaran G (1987) No effect of fish oil on natural killer cell activity and prostaglandin E2 synthesis in young and old mice. In: Lands WEM (ed) Proceedings of the American Oil Chemistry Society on polyunsaturated fatty acids and eicosanoids. American Oil Chemistry Society, Champaign, IL, USA, pp 438–441

    Google Scholar 

  29. Ortaldo JR, Herberman RB (1984) Heterogeneity of natural killer cells. Annu Rev Immunol 2: 359

    Google Scholar 

  30. Ortaldo JR, Winkler-Pickett R, Morgan AC, Woodhouse C, Kantor R, Reynolds CW (1987) Analysis of rat natural killer cytotoxic factor (NKCF) produced by rat NK cell lines and the production of a murine monoclonal antibody that neutralizes NKCF. J Immunol 139: 3159

    Google Scholar 

  31. Preble OT, Friedman RM (1983) Biology of disease. Interferon-induced alterations in cells: relevance to viral and nonviral diseases. Lab Invest 49: 4

    Google Scholar 

  32. Rager-Zisman B, Bloom BR (1982) Natural killer cells in resistance to virus-infected cells. Springer Semin Immunopathol 4: 397

    Google Scholar 

  33. Roder JC, Pross HF (1982) The biology of the human natural killer cell. J Clin Immunol 2: 249

    Google Scholar 

  34. Sinclair HM (1980) Drugs affecting lipid metabolism. Elsevier/North Holland Biomedical Press, Amsterdam, p 363–378

    Google Scholar 

  35. Sonnenfeld G, Merigan TC (1979) The role of interferon in viral infections. Springer Semin Immunopathol 2: 311

    Google Scholar 

  36. Stamler J (1983) Nutrition related risk factors for the athrosclerotic diseases: present status. Prog Biochem Pharmacol 19: 245

    Google Scholar 

  37. Stewart WE (1979) The interferon system. Springer, New York Berlin Heidelberg, pp 233–255

    Google Scholar 

  38. Trinchieri G, Perussia B (1982) Interferons and natural killer cells: interacting systems of nonspecific host defense. In: Herberman RB NK cells and other natural effector cells. Academic Press, New York, p 369–374

    Google Scholar 

  39. Welsh RM (1984) Natural killer cells and interferon. CRC Crit Rev Immunol 5: 55

    Google Scholar 

  40. Welsh RM, Biron CA, Bukowski JF, McIntyre KW, Yang H (1984) Role of natural killer cells in virus infections of mice. Surv Synth Pathol Res 3: 409

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gauntt, C.J., Godeny, E.K., Lutton, C.W. et al. Role of natural killer cells in experimental murine myocarditis. Springer Semin Immunopathol 11, 51–59 (1989). https://doi.org/10.1007/BF00197084

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00197084

Keywords

Navigation